{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:44:13Z","timestamp":1759761853730,"version":"build-2065373602"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-025-01360-3","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:07:25Z","timestamp":1759759645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BCR::ABL1-positive acute lymphoblastic leukemia as a high-risk feature of central nervous system relapse after allogeneic hematopoietic cell transplantation"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8465-2791","authenticated-orcid":false,"given":"Jong Hyuk","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daehun","family":"Kwag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gi-June","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8826-4136","authenticated-orcid":false,"given":"Sung-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9810-2050","authenticated-orcid":false,"given":"Sung-Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-6616","authenticated-orcid":false,"given":"Byung-Sik","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Seong","family":"Eom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoo-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-3366","authenticated-orcid":false,"given":"Hee-Je","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5429-4839","authenticated-orcid":false,"given":"Seok-Goo","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9442-9814","authenticated-orcid":false,"given":"Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-9131","authenticated-orcid":false,"given":"Jae-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"1360_CR1","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.bbmt.2014.07.005","volume":"20","author":"A Hamdi","year":"2014","unstructured":"Hamdi A, Mawad R, Bassett R, di Stasi A, Ferro R, Afrough A, et al. Central nervous system relapse in adults with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2014;20:1767\u201371. https:\/\/doi.org\/10.1016\/j.bbmt.2014.07.005.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1360_CR2","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.bbmt.2008.07.002","volume":"14","author":"K Oshima","year":"2008","unstructured":"Oshima K, Kanda Y, Yamashita T, Takahashi S, Mori T, Nakaseko C, et al. Central nervous system relapse of leukemia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2008;14:1100\u20137. https:\/\/doi.org\/10.1016\/j.bbmt.2008.07.002.","journal-title":"Biol Blood Marrow Transpl"},{"key":"1360_CR3","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41409-020-01097-6","volume":"56","author":"JH Yoon","year":"2021","unstructured":"Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, et al. Impact of donor type on long-term graft-versus-host disease-free\/relapse-free survival for adult acute lymphoblastic leukemia in first remission. Bone Marrow Transpl. 2021;56:828\u201340. https:\/\/doi.org\/10.1038\/s41409-020-01097-6.","journal-title":"Bone Marrow Transpl"},{"key":"1360_CR4","doi-asserted-by":"publisher","DOI":"10.1177\/20406207221076762","volume":"13","author":"JH Yoon","year":"2022","unstructured":"Yoon JH, Min GJ, Park SS, Park S, Lee SE, Cho BS, et al. Durable outcomes of double cord blood transplantation in adults with acute lymphoblastic leukemia: high-risk features for early and long-term mortality. Ther Adv Hematol. 2022;13:20406207221076762. https:\/\/doi.org\/10.1177\/20406207221076762.","journal-title":"Ther Adv Hematol"},{"key":"1360_CR5","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transpl. 2013;48:452\u20138. https:\/\/doi.org\/10.1038\/bmt.2012.244.","journal-title":"Bone Marrow Transpl"},{"key":"1360_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1182\/blood-2005-11-4666","volume":"108","author":"HM Lazarus","year":"2006","unstructured":"Lazarus HM, Richards SM, Chopra R, Litzow MR, Burnett AK, Wiernik PH, et al. Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII\/ECOG E2993. Blood. 2006;108:465\u201372. https:\/\/doi.org\/10.1182\/blood-2005-11-4666.","journal-title":"Blood"},{"key":"1360_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13045-025-01709-y","volume":"18","author":"NJ Short","year":"2025","unstructured":"Short NJ, Kantarjian H, Furudate K, Jain N, Ravandi F, Karrar O, et al. Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab. J Hematol Oncol. 2025;18:55. https:\/\/doi.org\/10.1186\/s13045-025-01709-y.","journal-title":"J Hematol Oncol"},{"key":"1360_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41586-018-0342-5","volume":"560","author":"H Yao","year":"2018","unstructured":"Yao H, Price TT, Cantelli G, Ngo B, Warner MJ, Olivere L, et al. Leukaemia hijacks a neural mechanism to invade the central nervous system. Nature. 2018;560:55\u201360. https:\/\/doi.org\/10.1038\/s41586-018-0342-5.","journal-title":"Nature"},{"key":"1360_CR9","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/leu.2009.49","volume":"23","author":"R Naughton","year":"2009","unstructured":"Naughton R, Quiney C, Turner SD, Cotter TG. Bcr-Abl-mediated redox regulation of the PI3K\/AKT pathway. Leukemia. 2009;23:1432\u201340. https:\/\/doi.org\/10.1038\/leu.2009.49.","journal-title":"Leukemia"},{"key":"1360_CR10","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.1002\/ajh.26622","volume":"98","author":"S Paul","year":"2023","unstructured":"Paul S, Kantarjian H, Sasaki K, Marx K, Jain N, Savoy JM, et al. Intrathecal prophylaxis with 12 versus 8 administrations reduces the incidence of central nervous system relapse in patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia. Am J Hematol. 2023;98:E11\u2013E14. https:\/\/doi.org\/10.1002\/ajh.26622.","journal-title":"Am J Hematol"},{"key":"1360_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1182\/blood-2008-02-140665","volume":"112","author":"K Porkka","year":"2008","unstructured":"Porkka K, Koskenvesa P, Lundan T, Rimpilainen J, Mustjoki S, Smykla R, et al. Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood. 2008;112:1005\u201312. https:\/\/doi.org\/10.1182\/blood-2008-02-140665.","journal-title":"Blood"},{"key":"1360_CR12","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1080\/10428194.2021.1894647","volume":"62","author":"K Ravi","year":"2021","unstructured":"Ravi K, Franson A, Homan MJ, Roberts H, Pai MP, Miklja Z, et al. Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice. Leuk Lymphoma. 2021;62:1990\u20134. https:\/\/doi.org\/10.1080\/10428194.2021.1894647.","journal-title":"Leuk Lymphoma"},{"key":"1360_CR13","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1182\/blood.2024024838","volume":"144","author":"P Walczak","year":"2024","unstructured":"Walczak P, Fodil S, Vignal N, Cabannes-Hamy A, Boissel N, Raffoux E, et al. Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1+ acute lymphoblastic leukemia. Blood. 2024;144:1127\u201330. https:\/\/doi.org\/10.1182\/blood.2024024838.","journal-title":"Blood"},{"key":"1360_CR14","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1200\/JCO.23.01075","volume":"42","author":"R Foa","year":"2024","unstructured":"Foa R, Bassan R, Elia L, Piciocchi A, Soddu S, Messina M, et al. Long-term results of the dasatinib-blinatumomab protocol for adult Philadelphia-positive ALL. J Clin Oncol. 2024;42:881\u20135. https:\/\/doi.org\/10.1200\/JCO.23.01075.","journal-title":"J Clin Oncol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01360-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01360-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01360-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T14:07:26Z","timestamp":1759759646000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-025-01360-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1360"],"URL":"https:\/\/doi.org\/10.1038\/s41408-025-01360-3","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The requirement for written informed consent was waived due to the retrospective nature of the study involving only de-identified data. This research was approved by the Seoul St. Mary\u2019s Hospital Data Review Board and the Institutional Review Board of The Catholic University of Korea (KC25RISI0296).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"159"}}